cobas e 801 immunoassay analyzer
Published May 8, 2019 · Recall initiated: March 15, 2019
Summary
FDA records medical device Class II recall Z-1249-2019, published May 8, 2019 and initiated March 15, 2019. Recalling firm: Roche Diagnostics Corporation; Status: Terminated; Reported quantity: 149; Lot: All units may experience this issue. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Corporation
- Distributor
- Distributed to accounts in AL AZ CA CT FL HI IA IL IN KY LA MA MD ME MI MN MO NC NH NJ NY OH OR PA PR SC TN TX VA WA WI
- Lot
- All units may experience this issue.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThe Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sampleJuly 24, 2019
- FDASOMATOM Definition AS with Option syngo DE Scan for Single Source (Dual Spiral Dual Energy scan mode), ModelMay 8, 2019
- FDACAROLINA(R) LIQUID CHEMISTRIES CORP. ETHA RGT. KIT, IVD, REF ST321May 8, 2019
- FDALactate Gen.2, Catalog Nos. 03183700190, 05171881190, 11822837190, ***added as of 5/10/19*** 03183700190April 24, 2019
- FDACoaguChek® XS System Prothrombin time test: CoaguChek XS PT Test 2X24 Strips, Catalog Number: 04625315160;November 14, 2018
- FDAcobas e 801 immunoassay analyzer, cobas 8000 Modular Series The device is a fully automated, softwareJune 20, 2018
Questions about this recall
Was cobas e 801 immunoassay analyzer recalled?
Yes. FDA published recall Z-1249-2019 on May 8, 2019. Reported hazard: The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.
What should I do if I have this product?
Voluntary: Firm initiated · Letter